|
Market Closed -
Nasdaq
16:00:00 2026-10-14 EDT
|
5-day change | 1st Jan Change | ||
| 88.66 USD | -0.39% |
|
-7.39% | -6.87% |
| 09-11 | Biontech Insider Sold Shares Worth $1,974,287, According to a Recent SEC Filing | MT |
| 09-10 | European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 22.36B | - | ||||
| 70.44B | |||||
| 50.31B | |||||
| 47.51B | |||||
| 42.91B | |||||
| 40.39B | - | - | - | - | - |
- Stock Market
- Stocks
- BNTX Stock
- Charts BioNTech SE
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
